Literature DB >> 6401163

Mutagen treatment as a means for selecting immunogenic variants from otherwise poorly immunogenic malignant murine tumors.

P Frost, R S Kerbel, E Bauer, R Tartamella-Biondo, W Cefalu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401163

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  26 in total

1.  Immunogenic (tum-) variants obtained by mutagenesis of mouse mastocytoma P815. VIII. Detection of stable transfectants expressing a tum- antigen with a cytolytic T cell stimulation assay.

Authors:  T Wölfel; A Van Pel; E De Plaen; C Lurquin; J L Maryanski; T Boon
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

2.  T cell-recognized antigenic peptides derived from the cellular genome are not protein degradation products but can be generated directly by transcription and translation of short subgenic regions. A hypothesis.

Authors:  T Boon; A Van Pel
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

3.  A 6-thioguanine-resistant variant of the rat mammary adenocarcinoma 13762 that is more immunogenic.

Authors:  D S Hoon; I A Ramshaw
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

Review 4.  On a possible epigenetic mechanism(s) of tumor cell heterogeneity. The role of DNA methylation.

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

5.  Retention of immunogenicity after X-irradiation of mouse colon tumor cells expressing the transfected influenza virus hemagglutinin gene.

Authors:  T Itaya; B Hunt; P Frost
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Decreased tumorigenicity correlates with expression of altered cell surface carbohydrates in Lec9 CHO cells.

Authors:  J Ripka; S Shin; P Stanley
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

Review 7.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

Review 8.  Tumor cell surface carbohydrate and the metastatic phenotype.

Authors:  J W Dennis; S Laferte
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

9.  Metastatic phenotype of human prostate tumor cells in athymic nude mice: alteration by exposure to ethyl methanesulfonate and "reversion" by 5-azacytidine.

Authors:  J L Ware; A P Lieberman; K S Webb
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

10.  Development of highly immunogenic variants of a rat fibrosarcoma line during in vitro cultivation.

Authors:  K Yamashina; T Oikawa; M Kasai; M Naiki; I Chiba; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.